🔗 Share this article

Grammy-winning R&B singer D’Angelo passed away on October 14 at age 51 after a personal fight with pancreatic malignancy.

“The shining star of our family has faded away for us in this life,” his relatives confirmed. “After a lengthy and brave battle with the disease, we are deeply saddened to declare that D’Angelo, known to his followers around the globe as D’Angelo, has been called home.”

D’Angelo made a lasting impact on music with his innovative neo-soul sound and partnerships with high-profile artists.

He launched his debut album, “Brown Sugar,” in 1995 to immediate acclaim. The album achieved No. 4 on Billboard’s Top R&B Albums chart, earned platinum status soon after, and earned several award nominations.

However, it was his second album, “Voodoo,” in 2000 that propelled his artistic journey into the limelight. The record premiered at the top spot on each of Billboard’s Top R&B Albums chart and the Billboard 200. He won two Grammys: Top R&B Record and Best Male R&B Vocal Performance for “Untitled (How Does It Feel).”

The visual for “Untitled (How Does It Feel)” cemented D’Angelo’s standing as a sex symbol, albeit a reluctant one, in the cultural zeitgeist. The intimate portrayal featured the singer, notably bare to his waist, performing straight into the lens.

D’Angelo retreated from the spotlight after putting out Voodoo and publicly struggled with drugs and alcohol. In 2005, he was part of a serious vehicle accident that put him in grave health.

Over ten years later, his last record, “Black Messiah” (2014), reaffirmed his enduring appeal with another No. 1 debut on the soul music rankings and a award for Top R&B Record.

Again, in his own enigmatic fashion, D’Angelo made only a few public appearances in the following years.

The singer was announced as a headliner for the 2025 Roots Picnic festival, but his performance was canceled, due to an “unforeseen medical delay.”

Although details are sparse about D’Angelo’s well-being in the weeks leading up to his passing, he had reportedly been in the hospital for months and in palliative care for a fortnight.

D’Angelo’s passing is a stark reminder of the devastating effects of pancreatic malignancy, one of the deadliest and hardest to prevent forms of the disease, on a brilliant talent whose life was cut short.

“We are grieved that he can only provide dear memories with his family, but we are forever thankful for the legacy of deeply emotional music he leaves behind,” his kin said.

Pancreatic Cancer: Lethal and Rarely Preventable

Pancreatic cancer impacts the digestive organ, a tiny gland that produces the hormone insulin and plays an essential role in digestion, among other functions. The size and location of the organ in the human system make it more challenging to identify malignancy.

Although pancreatic cancer makes up only approximately three percent of cancer diagnoses each year in the U.S., it is causes seven percent of cancer deaths.

Almost 70,000 individuals will be diagnosed with this condition and about 52,000 will die of the illness in 2025.

“Pancreatic cancer is one of the most lethal diseases, with an aggressive tumor and poor prognosis. We have few and poor therapies, and a smaller window to make a significant difference on the well-being of people,” noted a cancer specialist.

Because pancreatic cancer rarely causes initial signs, it’s frequently diagnosed only once the condition is advanced. Although a patient has indicators they are often nonspecific and may be mistaken for a number of everyday ailments.

“As of yet, there is no good way to detect pancreatic cancer in the early stages, except for paying attention to physical changes and speaking with your doctor if there are unfamiliar signs,” said a medical director.

Common symptoms of this disease include:

• discomfort in the stomach or back
• weight loss
• yellowing of skin and eyes
• reduced hunger
• dark urine
• light-colored or greasy stools
• diarrhea
• increased appetite or thirst
• feeling sick

At age 51, D’Angelo’s death is an exception, as this malignancy is typically found in individuals in the 65 to 75 range. However, many cancers, including this type, have become more common among younger adults.

“This disease diagnosed before the age of 50 is deemed uncommon, yet concerningly, doctors are noticing a growing number of younger patients suffering from this disease,” said a specialist.

Genetic Background Affects Disease Probability

Without effective detection methods for pancreatic cancer, experts stressed the significance of knowing your relatives’ cancer history. Some risk factors, such as tobacco use and excess weight also have an influence in the onset of this disease.

Black individuals have the greatest occurrence of pancreatic cancer in the U.S. and are more prone to be found to have inoperable cancer.

“The first step toward reducing one’s risk of this condition is assessing personal risk factors. Individuals should review their genetic background, genetic background, and health issues, such as blood sugar disease, long-term pancreas inflammation, or obesity that may increase their susceptibility,” advised a specialist.

Hereditary risk factors are linked to as much as 10% of all this malignancy cases. If a relative in your family has had pancreatic cancer, you may want to consider DNA analysis.

“For individuals with a family history of pancreatic cancer or those having high risk genetic mutations, checking may involve advanced imaging such as magnetic resonance imaging (MRI) or endoscopic ultrasound (EUS) to find initial alterations in the organ,” he clarified.

For those wishing to lower their chance, lifestyle changes may have an effect. The most effective action you can take to lower your risk of pancreatic cancer is to stop tobacco use, and if you don’t smoke, stay away altogether.

Excessive alcohol consumption is associated with pancreas inflammation, a contributing element for this malignancy, so limiting or abstaining from alcohol may help reduce your risk.

Managing your weight or losing weight may also aid reduce your risk. People with excess weight are 20% more likely to develop this disease. Pancreatic cancer also occurs more often in people with diabetes, and reducing weight can also lower the chance of type 2 diabetes.

Despite pancreatic cancer’s grim outlook, there is still hope.

“We are doing better with therapies and newer combination chemotherapy. There are developing precision medicines that already are making an impact,” said a specialist.

For numerous individuals, however, awareness about this uncommon but {dev